the impact of complex karyotype on treatment efficacy and prognosis in cll
Published 1 year ago • 137 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
3:40
are complex karyotypes reliable prognostic markers for cll?
-
2:12
the impact of genetic abnormalities on treatment decisions in cll
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
1:29
the importance of treatment sequencing in cll
-
0:45
key trials in cll and designing a concept for treatment
-
5:33
leukemia, causes, signs and symptoms, diagnosis and treatment.
-
4:18
treatment options for chronic lymphocytic leukemia (cll)
-
2:34
the impact of gene mutations on prognosis in cll
-
3:16
prognostic markers for the treatment of cll
-
1:28
the future of cll treatment
-
3:14
understanding cll pathogenesis by assessing clonotypes
-
2:20
adverse prognostic features & treatment response in cll
-
2:08
disease characteristics impacting treatment decisions in cll
-
1:43
biomarker-guided therapy in cll
-
3:01
cell-intrinsic biomarkers in cll: focus on cytogenetics
-
0:56
the current treatment landscape in cll
-
5:35
clinical and prognostic significance of aberrant t-cell marker expression in aml
-
0:53
the future of cll treatment
-
1:04
defining high-risk cll: known and emerging mutations
-
1:00
the future of cll treatment: chemotherapy and targeted inhibitors
-
1:19
cll treatment: a look into the future
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma